+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
ID06905054

Evaluating Daily Fenofibrate to Prevent Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation Over 36 Months

Led by Mayo Clinic · Updated on 2026-07-17

80

Participants Needed

1

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

The trial investigates the use of once-daily fenofibrate over 36 months to prevent recurrence of primary sclerosing cholangitis PSC after liver transplantation. PSC is a progressive liver disease with no established drug treatment and often leads to liver transplants. Recurrence of PSC after transplant is common and can cause serious complications including graft loss. This study compares fenofibrate-treated patients to a historical control group without such treatment to evaluate prevention of recurrent PSC. Participants who had liver transplantation for PSC 1 to 7 years prior and meet study criteria will receive fenofibrate 160mg daily for 36 months. During this time, serum markers related to bile acid metabolism and inflammation will be measured every 3 months. Participants will also undergo specialized gadoxetate-enhanced MRI scans at baseline, 12 months, and 36 months to assess bile duct function and early signs of disease recurrence. Throughout the study, researchers will monitor for clinically detectable recurrent PSC and analyze associations between blood markers and imaging results with disease development. The main outcome is the incidence of recurrent PSC after 36 months of fenofibrate treatment compared to controls. The trial includes periodic blood draws and MRI assessments and aims to improve understanding of biomarkers and imaging techniques for early detection. The total participation duration is 36 months of treatment with ongoing monitoring.

CONDITIONS

Brief Title

Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here